Avalo Therapeutics, Inc. (AVTX)
14.41
-1.51
(-9.48%)
USD |
NASDAQ |
Apr 08, 16:00
15.48
+1.07
(+7.43%)
After-Hours: 20:00
Avalo Therapeutics Market Cap : 328.38M for April 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 374.13B |
| Corcept Therapeutics, Inc. | 4.454B |
| Catalyst Pharmaceuticals, Inc. | 3.091B |
| Relmada Therapeutics, Inc. | 735.28M |
| Theravance Biopharma, Inc. | 854.78M |
Market Cap Related Metrics
| PS Ratio | 2980.75 |
| Price to Book Value | 3.584 |
| Price | 14.41 |
| Earnings Yield | -46.68% |